4.4 Review

The Microbiome in Hidradenitis Suppurativa: A Review

期刊

DERMATOLOGY AND THERAPY
卷 11, 期 1, 页码 39-52

出版社

ADIS INT LTD
DOI: 10.1007/s13555-020-00465-w

关键词

Bacteria; Hidradenitis suppurativa; Infections; Gastrointestinal microbiome; Microbiota

向作者/读者索取更多资源

A chronic autoinflammatory skin disease called Hidradenitis suppurativa (HS) is characterized by the development of abscesses and nodules in intertriginous anatomical sites. Bacteria play a role in disease pathogenesis. Research found studies examining the cutaneous microbiome and gut microbiome in HS, with potential for further research into the oral microbiome and relationship with co-morbidities. Metagenomics-focused studies may identify new pathways of disease pathogenesis and potential therapeutic targets.
Introduction Hidradenitis suppurativa (HS) is a chronic autoinflammatory skin disease. It is characterised by the development of abscesses and nodules in intertriginous anatomical sites. Whilst it is now recognised as an autoinflammatory condition rather than an infective disease, bacteria are implicated in disease pathogenesis. Methods We performed a search of the literature from inception to 12 August 2020 using the search terms hidradenitis suppurativa, Verneuil's disease, acne inversa, microbiome, bacteriology and microbiology. Studies were included if they assessed the cutaneous, gut or oral bacteria, bacteriology or microbiome in hidradenitis suppurativa. Results Twenty-one studies examining the cutaneous microbiome and two studies examining the gastrointestinal microbiome in HS were identified. No studies examining the oral microbiome in HS were identified. A total of 972 patients and 46 healthy controls were included across studies examining the cutaneous microbiome. A total of 100 patients and 36 controls were included across both gut microbiome studies. Coagulase-negative Staphylococcus, anaerobes such as Porphyromonas and Prevotella, and Staphylococcus aureus species were commonly encountered organisms across the included cutaneous microbiome studies. The studies examining the gut microbiome were limited, with one small study demonstrating an alteration in the gut microbiome composition compared to controls. The other study found no alteration to the gut microbiome in patients with HS compared to those with inflammatory bowel disease (IBD) and HS, and IBD and/or psoriasis. Conclusion Research should be undertaken into the oral microbiome in HS. Further research should be undertaken examining the cutaneous and gut microbiome in HS, and its relationship with documented co-morbidities. Additionally, metagenomics-focused studies may help identify the relationship between microorganisms and host, and this may shed light on new pathways of disease pathogenesis. This may help identify potential future therapeutic targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据